Antitrust Agency Response to 2019 Novel Coronavirus Disease (COVID-19) | Practical Law
In response to 2019 Novel Coronavirus Disease (COVID-19), the US federal antitrust agencies have taken action to protect their employees and continue operations, including a move to a teleworking model and accepting electronic Hart-Scott-Rodino (HSR) filings. This resource discusses COVID-19's impact on the antitrust agencies' merger and enforcement activities. For the most up-to-date guidance on the agencies' actions due to the COVID-19 event, see Practice Note, Antitrust COVID-19 Agency Guidance and Procedural Changes.